出典:Wikipedia
出典:『Wikipedia』 (2011/04/20 09:42 UTC 版)
Bucindolol is a non-selective beta blocker with additional weak alpha-blocking properties and some intrinsic sympathomimetic activity. It was under review by the FDA in the United States for the treatment of heart failure in 2009 but was rejected.